(PharmaNewsWire.Com, December 21, 2017 ) Obesity Management Market Companies Involved: F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline plc. (UK), AstraZeneca (UK), Herbalife Ltd. (U.S.), Apollo Endosurgery (U.S.), Ethicon, Inc. (U.S.), Pfizer Inc. (US), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (US)
Obesity Management Market is Getting Hike Moderately. Studies have demonstrated that an eating regimen high in dairy diminishes add up to muscle versus fat. This happens on the grounds that a high measure of dietary calcium builds the measure of vitality and fat discharged from the body. Different investigations particularly demonstrate that dairy wellsprings of calcium show more noteworthy weight reduction than supplemental calcium consumption.
Obesity Management Market is expected to grow at the average CAGR of 8.4% during 2015-2022. Obesity management Market is expected to reach US$ 6.2 billion by 2022 from US$ 4.17 billion in 2015.
Obesity management Market is growing moderately. Changing lifestyle and unhealthy eating habits are leading to the problem of obesity. The population of obese people are increasing globally. Obesity leads to various diseases such as diabetes, hypertension, heart diseases and many others. Drugs manufacturers investing their money in R&D to develop effective anti-obesity drugs. Earlier obesity was considered as problem of high income countries but now it’s shifting towards low-middle income countries. Healthcare solution providers are developing new and innovative solutions for healthcare sector. Hospitals also providing different surgery options according to medical history and condition of the patient. Deliberate weight reduction is the loss of aggregate weight because of endeavors to enhance wellness and wellbeing, or to change appearance through thinning. Weight reduction in people who are overweight or large can diminish wellbeing dangers, increment wellness and may defer the beginning of diabetes.
Market Segments: On the premise of Prescription weight reduction solution which involve orlistat (Xenical), lorcaserin (Belviq), phentermine and topiramate (Qsymia), buproprion and naltrexone (Contrave), and liraglutide (Saxenda), and others. On the premise of Surgery it fragmented into Gastric sidestep surgery, Laparoscopic movable gastric banding (LAGB), Biliopancreatic preoccupation with duodenal switch, and others. On the premise of way of life transforms it is sectioned into Dietary changes, Exercise, and others.
Regional Analysis of Obesity Management Market: Prior weight was considered as issue of high wage nations however now it's moving towards low-center wage nations. Medicinal services arrangement suppliers are growing new and inventive answers for human services segment. Doctor's facilities likewise giving distinctive surgery choices as per medicinal history and state of the patient. Considering the global scenario of the market, North America region is believed to be the largest market for Obesity management. Moreover the European market is also growing and second largest market for Obesity management.
The report for Obesity Management Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
LIST OF FIGURES:
Figure 1 Research Process
Figure 2 Porters Five Forces Model
Figure 3 Global Obesity Management Market, By Prescription Weight-Loss Medication
Figure 4 Global Obesity Management Market, By Surgery
Figure 5 Global Obesity Management Market, By End User
Figure 6 Global Obesity Management Market, By Region
Figure 7 Global Obesity Management Market: Company Share Analysis, 2015 (%)
Browse Report @ https://www.marketresearchfuture.com/reports/obesity-management-market-2690 .Obesity Management Market Companies Involved: F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline plc. (UK), AstraZeneca (UK), Herbalife Ltd. (U.S.), Apollo Endosurgery (U.S.), Ethicon, Inc. (U.S.), Pfizer Inc. (US), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (US)
Obesity Management Market is Getting Hike Moderately. Studies have demonstrated that an eating regimen high in dairy diminishes add up to muscle versus fat. This happens on the grounds that a high measure of dietary calcium builds the measure of vitality and fat discharged from the body. Different investigations particularly demonstrate that dairy wellsprings of calcium show more noteworthy weight reduction than supplemental calcium consumption.
Obesity Management Market is expected to grow at the average CAGR of 8.4% during 2015-2022. Obesity management Market is expected to reach US$ 6.2 billion by 2022 from US$ 4.17 billion in 2015.
Obesity management Market is growing moderately. Changing lifestyle and unhealthy eating habits are leading to the problem of obesity. The population of obese people are increasing globally. Obesity leads to various diseases such as diabetes, hypertension, heart diseases and many others. Drugs manufacturers investing their money in R&D to develop effective anti-obesity drugs. Earlier obesity was considered as problem of high income countries but now it’s shifting towards low-middle income countries. Healthcare solution providers are developing new and innovative solutions for healthcare sector. Hospitals also providing different surgery options according to medical history and condition of the patient. Deliberate weight reduction is the loss of aggregate weight because of endeavors to enhance wellness and wellbeing, or to change appearance through thinning. Weight reduction in people who are overweight or large can diminish wellbeing dangers, increment wellness and may defer the beginning of diabetes.
Market Segments: On the premise of Prescription weight reduction solution which involve orlistat (Xenical), lorcaserin (Belviq), phentermine and topiramate (Qsymia), buproprion and naltrexone (Contrave), and liraglutide (Saxenda), and others. On the premise of Surgery it fragmented into Gastric sidestep surgery, Laparoscopic movable gastric banding (LAGB), Biliopancreatic preoccupation with duodenal switch, and others. On the premise of way of life transforms it is sectioned into Dietary changes, Exercise, and others.
Regional Analysis of Obesity Management Market: Prior weight was considered as issue of high wage nations however now it's moving towards low-center wage nations. Medicinal services arrangement suppliers are growing new and inventive answers for human services segment. Doctor's facilities likewise giving distinctive surgery choices as per medicinal history and state of the patient. Considering the global scenario of the market, North America region is believed to be the largest market for Obesity management. Moreover the European market is also growing and second largest market for Obesity management.
The report for Obesity Management Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
LIST OF FIGURES:
Figure 1 Research Process
Figure 2 Porters Five Forces Model
Figure 3 Global Obesity Management Market, By Prescription Weight-Loss Medication
Figure 4 Global Obesity Management Market, By Surgery
Figure 5 Global Obesity Management Market, By End User
Figure 6 Global Obesity Management Market, By Region
Figure 7 Global Obesity Management Market: Company Share Analysis, 2015 (%)
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
